Variant report
Variant | esv34795 |
---|---|
Chromosome Location | chr13:54691999-54695928 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr13:54693602..54695448-chr13:54696284..54698888,2 | MCF-7 | breast: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PCDH8-5 | chr13:54695075-54695179 | ENSG00000234787.3 |
2 | lnc-PCDH8-5 | chr13:54695071-54695179 | ENSG00000234787 |
No data |
No data |
Variant related genes | Relation type |
---|---|
POU5F1 | lncRNA |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2408992 | chr13:54692000-54692001 | Weak transcription Genic enhancers Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs1335980 | chr13:54692006-54692007 | Weak transcription Genic enhancers Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs111978538 | chr13:54692018-54692019 | Weak transcription Genic enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs112814291 | chr13:54692019-54692020 | Weak transcription Genic enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs79447735 | chr13:54692020-54692021 | Weak transcription Genic enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs397770475 | chr13:54692021-54692022 | Weak transcription Genic enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs2260462 | chr13:54692032-54692033 | Weak transcription Genic enhancers Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs556099173 | chr13:54692079-54692080 | Weak transcription Genic enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs531938880 | chr13:54692122-54692123 | Weak transcription Genic enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs551873521 | chr13:54692173-54692174 | Weak transcription Genic enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs560039467 | chr13:54692192-54692193 | Weak transcription Genic enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs576132994 | chr13:54692250-54692251 | Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs528757901 | chr13:54692277-54692278 | Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs186395950 | chr13:54692330-54692331 | Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs535248027 | chr13:54692333-54692334 | Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs568634186 | chr13:54692337-54692338 | Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs17089288 | chr13:54692342-54692343 | Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs551048220 | chr13:54692376-54692377 | Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs2408993 | chr13:54692377-54692378 | Strong transcription Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs189342500 | chr13:54692410-54692411 | Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs576557769 | chr13:54692463-54692464 | Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs558927015 | chr13:54692516-54692517 | Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs553090791 | chr13:54692517-54692518 | Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs565994998 | chr13:54692574-54692575 | Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs139029760 | chr13:54692594-54692595 | Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs554767010 | chr13:54692602-54692603 | Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs542260322 | chr13:54692659-54692660 | Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs79641890 | chr13:54692713-54692714 | Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs556677999 | chr13:54692841-54692842 | Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs1984141 | chr13:54692859-54692860 | Strong transcription Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs541389079 | chr13:54692860-54692861 | Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs561647514 | chr13:54692888-54692889 | Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs1335979 | chr13:54692892-54692893 | Strong transcription Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs543449094 | chr13:54692935-54692936 | Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs528797528 | chr13:54692963-54692964 | Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs375413009 | chr13:54692964-54692965 | Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs562268748 | chr13:54692974-54692975 | Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs1984140 | chr13:54693040-54693041 | Strong transcription Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs373032079 | chr13:54693053-54693054 | Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs142232573 | chr13:54693091-54693092 | Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs117947362 | chr13:54693093-54693094 | Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs533248564 | chr13:54693124-54693125 | Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs547009510 | chr13:54693152-54693153 | Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs566720477 | chr13:54693270-54693271 | Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs180958128 | chr13:54693296-54693297 | Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs185913499 | chr13:54693299-54693300 | Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs568003031 | chr13:54693305-54693306 | Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs2784558 | chr13:54693324-54693325 | Strong transcription Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs556713131 | chr13:54693329-54693330 | Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs562033761 | chr13:54693373-54693374 | Strong transcription Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 19242612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Multiple myeloma | 19135901 | CNVD |
Autism | 18414403 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Prostate cancer | 16461572 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Gastric cancer | 17908304 | CNVD |
Breast cancer | 18852474 | CNVD |
Myelofibrosis | 22110671 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:54678000-54692000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
2 | chr13:54683200-54698800 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
3 | chr13:54688600-54692200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
4 | chr13:54688600-54699000 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr13:54689000-54706000 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
6 | chr13:54689400-54700000 | Strong transcription | HUES6 Cell Line | embryonic stem cell |
7 | chr13:54691000-54692000 | Weak transcription | H9 Cell Line | embryonic stem cell |
8 | chr13:54691800-54706000 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
9 | chr13:54692000-54692200 | Genic enhancers | H9 Cell Line | embryonic stem cell |
10 | chr13:54692000-54695400 | Strong transcription | HUES64 Cell Line | embryonic stem cell |
11 | chr13:54692200-54693800 | Strong transcription | ES-I3 Cell Line | embryonic stem cell |
12 | chr13:54692200-54695800 | Strong transcription | H9 Cell Line | embryonic stem cell |
13 | chr13:54692600-54705000 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
14 | chr13:54693800-54700000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
15 | chr13:54695400-54697200 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
16 | chr13:54695800-54697600 | Weak transcription | H9 Cell Line | embryonic stem cell |